Position in EXEL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$70,673,525
+$35,896,215 QoQ
Shares Held
1,298,907
+60.2% QoQ
Ownership
0.524%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. EXEL ranks #22 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,673,525 | 1,298,907 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $34,777,310 | 810,849 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $33,256,447 | 758,760 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $38,902,491 | 941,949 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $52,469,875 | 1,190,333 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $35,117,748 | 951,185 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $110,375,345 | 3,314,575 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $114,975,444 | 4,430,653 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $113,447,793 | 5,048,856 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $126,335,172 | 5,323,859 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $185,720,717 | 7,741,589 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $167,113,626 | 7,648,221 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $147,064,213 | 7,695,668 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $150,707,914 | 7,764,447 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $200,820,058 | 12,519,954 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $193,642,181 | 12,349,629 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $252,940,158 | 12,148,903 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $273,096,486 | 12,046,603 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $218,325,550 | 11,943,411 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $241,610,642 | 11,429,075 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $257,505,882 | 14,133,144 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $256,672,457 | 11,362,216 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $234,060,572 | 11,662,211 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $238,808,331 | 9,767,212 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $230,343,376 | 9,702,754 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $146,610,819 | 8,513,985 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||